FDG-PET/CT in high-risk primary breast cancer—a prospective study of stage migration and clinical impact

被引：0
|
作者：
Marianne Vogsen
Jeanette Dupont Jensen
Ivar Yannick Christensen
Oke Gerke
Anne Marie Bak Jylling
Lisbet Brønsro Larsen
Poul-Erik Braad
Katrine Lydolph Søe
Camilla Bille
Marianne Ewertz
Malene Grubbe Hildebrandt
机构：
[1] Odense University Hospital,Department of Oncology
[2] Odense University Hospital,Department of Nuclear Medicine
[3] University of Southern Denmark,Department of Clinical Research
[4] Odense University Hospital,Odense Patient Data Explorative Network
[5] Odense University Hospital,Centre for Personalized Response Monitoring in Oncology (PREMIO)
[6] Odense University Hospital,Department of Radiology
[7] Odense University Hospital,Department of Pathology
[8] Odense University Hospital,Department of Breast Surgery
[9] Odense University Hospital,Department of Plastic Surgery
[10] Odense University Hospital,Centre for Innovative Medical Technology
[11] Odense University Hospital,Department of Oncology and Department of Nuclear Medicine
来源：
Breast Cancer Research and Treatment | 2021年 / 185卷
关键词：
Breast cancer; FDG-PET/CT; Stage migration; Clinical impact; Incidental findings;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：145 / 153
页数：8
相关论文
共 50 条
  • [1] FDG-PET/CT in high-risk primary breast cancer: A prospective study of stage migration and clinical impact
    Vogsen, M.
    Jensen, J. D.
    Christensen, I. Y.
    Gerke, O.
    Jylling, A. M. B.
    Larsen, L. B.
    Braad, P-E.
    Soe, K. L.
    Bille, C.
    Ewertz, M.
    Hildebrandt, M. G.
    ANNALS OF ONCOLOGY, 2020, 31 : S340 - S340
  • [2] FDG-PET/CT in high-risk primary breast cancer-a prospective study of stage migration and clinical impact
    Vogsen, Marianne
    Jensen, Jeanette Dupont
    Christensen, Ivar Yannick
    Gerke, Oke
    Jylling, Anne Marie Bak
    Larsen, Lisbet Bronsro
    Braad, Poul-Erik
    Soe, Katrine Lydolph
    Bille, Camilla
    Ewertz, Marianne
    Hildebrandt, Malene Grubbe
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 185 (01) : 145 - 153
  • [3] FDG-PET/CT for diagnosing recurrent breast cancer - a prospective study of diagnostic accuracy and clinical impact
    Vogsen, Marianne
    Jensen, Jeanette
    Gerke, Oke
    Jylling, Anne Marie
    Asmussen, Jon
    Braad, Poul-Erik
    Thye-Roenn, Peter
    Soe, Katrine
    Ewertz, Marianne
    Hildebrandt, Malene
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [4] Male primary breast cancer found on FDG-PET/CT
    McEachen, James C.
    Kuo, Phillip H.
    CLINICAL NUCLEAR MEDICINE, 2008, 33 (09) : 630 - 632
  • [5] FDG-PET/CT predicts survival in high-risk Neuroblastoma
    Papathanasiou, N.
    Sullivan, K.
    Aldridge, M.
    Soderlund, T.
    Waddington, W.
    Gaze, M.
    Bomanji, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S253 - S253
  • [6] FDG-PET and PET/CT in breast cancer staging
    Avril, Norbert
    Mather, Stephen J.
    Roylance, Rebecca
    BREAST CARE, 2007, 2 (06) : 372 - 377
  • [7] Role of FDG PET/CT in the preoperative staging of high-risk clinical early stage endometrial cancer
    Crivellaro, Cinzia
    Guerra, Luca
    Signorelli, Mauro
    Mapelli, Paola
    De Ponti, Elena
    Picchio, Maria
    Pirovano, Cecilia
    Milani, Rodolfo
    Messa, Cristina
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [8] Is FDG-PET/CT useful in initial evaluation of patients with clinical stage II breast cancer?
    Groheux, David
    Espie, Marc
    Vercellino, Laetitia
    Hamy, Anne-Sophie
    Giacchetti, Sylvie
    Berenger, Nathalie
    Misset, Jean-Louis
    Hindie, Elif
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [9] FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer
    Groheux, David
    SEMINARS IN NUCLEAR MEDICINE, 2022, 52 (05) : 508 - 519
  • [10] Compairing FDG-PET/CT with MIBG scans for Staging of Relapse Stage IV High-Risk Neuroblastoma
    Fania, P.
    Quartuccio, N.
    Asaftei, S.
    Barat, V.
    Postini, A. M.
    Bianchi, M.
    Fagioli, F.
    Cistaro, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S252 - S252
12345